Onconova Therapeutics (ONTX) Reports Q3 Loss of $0.29/Share

Onconova Therapeutics (NASDAQ: ONTX) reported Q3 EPS of ($0.29), versus ($2.60) reported last year. Revenue for the quarter came in at $1.7 million, versus $1.6 million reported last year.

For earnings history and earnings-related data on Onconova Therapeutics (ONTX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Sinda raises $331M in IPO, reports Q2 net loss of $16.6M
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c